Long term investing is the way to go, but that doesn't mean you should hold every stock forever. We really hate to ...

Williamsville struggled shooting against Auburn for a fifth straight quarter, but unlike the January Sangamon County ...

Pleasant Plains edged Petersburg PORTA for the Sangamo title, plus other conference champions in the Springfield area in boys ...

Sangamo Therapeutics has higher earnings, but lower revenue than Novavax. Novavax is trading at a lower price-to-earnings ratio than Sangamo Therapeutics, indicating that it is currently the more ...

Pfizer terminated partnership with Sangamo on hemophilia A gene therapy despite positive Phase 3 data, following a pattern of big pharma partners ending collaborations. Current hemophilia A market ...

The move comes weeks after Pfizer terminated its partnership with Sangamo Therapeutics for another hemophilia gene therapy.

Sangamo Therapeutics has a one year low of $0.30 and a one year high of $3.18. The firm has a market cap of $223.26 million, a price-to-earnings ratio of -1.43 and a beta of 1.30. About Sangamo ...

Pfizer has ended the global commercialisation of its haemophilia B (factor IX deficiency) gene therapy Beqvez, citing soft ...

RICHMOND, Calif. - Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company with a market capitalization of $263 million, has announced promising updated results from its Phase 1/2 ...

Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...